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A  subset  of T  cell  surface  antigens  have  been  shown  to play a  role  in  the 
response of T  cells to target cells. These molecules do not seem to be part of the 
antigen (Ag)-specific, major histocompatibility complex (MHC)-restricted recep- 
tor on T  cells since they do not vary between T  cell clones, yet antibodies against 
these molecules very frequently inhibit responses of T  cells to Ag/MHC (1-4). 
For example, the lymphocyte function-associated antigen-1 (LFA-1) seems to be 
active in a broad range of T  cell functions with no relation to the specificity of 
the response (5, 6). 
In  murine  systems,  all  reports  so  far of the  effects of monoclonal antibody 
directed against  LFA-1  on T  cell function  have analyzed the  interaction of T 
cells with cells of leukocytic lineage.  In this paper we present data which show 
that  anti-LFA-1  does  not  inhibit  the  responses  of T  cell  hybridomas  to  Ag 
presented by nonleukocytic fibroblast cells derived from the L  cell line, nor to 
polyvalent anti-T cell receptor antibodies, although the responses of these same 
T  cell  hybridomas  to  Ag  presented  by  leukocytic  cells  are  sensitive  to  the 
antibody.  These results imply that  LFA-1  does not play an  essential  role in  T 
cell activation,  and  that  the  molecule may interact with  iigands  on  leukocytic 
target cells which are absent from L cells. 
Materials and Methods 
Culture Medium.  Cells were cultured in medium prepared by the recipe of Mishell and 
Dutton (7), with the exception that the medium was supplemented before use with 10% 
nutrient cocktail and contained 10% fetal bovine serum, 5 ×  10  -~ M 2-mercaptoethanol, 
and 50 #g/ml gentamicin (Shering Corp., Kenilworth, NJ). Transfected fibroblast lines 
were cultured in the same medium with hypoxanthine, aminopterin, and thymidine (HAT) 
added to maintain selection for cells expressing the transfected genes. 
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TABLE  I 
Monoclonal Antibodies Used in These Studies 
Antibody  Specificity  Source  Reference 
12 !/7.7  LFA- 1  Culture SN  8 
GK-1.5  L3T4  Culture SN  3 
KJ 12-98.15  Self-D  d receptor on T cell hybrid 3DT-52.5  Culture SN  9 
KJ 1-26.1  Receptor for OVA/I-A  d on T cell hybridoma,  DO-  Culture SN  9 
11.10 
Reagents.  Keyhole limpet hemocyanin (KLH) and ovalbumin (OVA),  obtained from 
Sigma Chemical Co., St.  Louis, MO, were used as Ag in these experiments. Alkaline 
phosphatase--conjugate(' rabbit anti-rat immunoglobulin and p-nitrophenyl phosphate 
were also purchased from Sigma Chemical Co. 
Monodonal Antibodies.  Monoclonal antibodies were prepared as cell-free culture su- 
pernatants (SN) of hybridoma c  ures grown to a cell concentration of 10  e cells/ml. A 
list of the monoclonal antibodies used in these experiments is given in Table I. Monoclonal 
antibody culture supernatants were used neat. 
T Cell Hybr/d0mas.  T  cell hybridomas for these experiments were prepared by fusing 
Ag/MHC-reactive T  cell blasts to BW5147 by standard procedures (10). The properties 
of these T  cell hybridomas have been described elsewhere (10). 
Transfected  Fibroblast  Lines.  Two different transfected fibroblast lines were used in 
these studies. Both are products of transfections of L cells, C3H-derived fibroblast tumor 
cells, made thymidine kinase negative (TK-) to render them HAT sensitive. Transfections 
were done with plasmid constructs containing the genes of interest plus the thymidine 
kinase gene. The first cell line, CA14.11.14, was transfected with the genes for I-A  k (11). 
The second cell line, a generous gift of Dr.John Seidman (Harvard University, Cambridge, 
MA) was transfected with the genes for D  d (12). 
lnterleukin 2 (tL-2) Assay for T Cell Hybridoma Activity.  T cell hybridomas' recognition 
of Ag]MHC  or  stimulation by polyvalent anti-receptor antibody was  assayed by the 
secretion of IL-2 by these hybridomas (10).  None of these hybridomas made detectable 
IL-2 in the absence of the appropriate  Ag/MHC or other stimulus. To induce IL-2 
production, 104 hybridoma T cells were incubated for 24 h with the appropriate Ag and 
10  ~ antigen-presenting cells (APC), or with anti-receptor antibodies coupled to Sepharose 
heads in 250-~1 cultures. Ag concentrations were always 500-1,000 t~g/mi. 
Results are expressed as units per milliliter of IL-2 secreted by the T  cell hybridomas 
under different conditions. 10 U/ml IL-2 was the minimum detectable using this assay. 
A20.2J, a  BALB/c B cell  lymphoma, and P815, a  DBA/2 mastocytoma, were used to 
stimulate a Da-specific T cell hybridoma; LK-4.5, a B cell hybridoma, was used to present 
k  Ag to I-A -restricted T cell hybridomas. 
ELISAfor Cell Surface Antigens.  We assayed for the expression of cell surface antigens 
by the standard enzyme-linked immunosorhent assay (ELISA) (13). This assay was slightly 
modified to use a vacuum plate system from MiUipore Corp. (Bedford, MA). 
Results and Discussion 
It  has  been  reported  previously  that  the  L  cell  transfectant  CA14-11.14 
expresses the transfected gene product I-A  k in sufficient concentration to serve 
as a  presenting  cell  to  I-Ak-restricted,  Ag-specific T  cell  hybridomas.  This  is 
illustrated in  Fig.  1,  which shows that  two  l-Ak-restricted  T  cell  hybridomas, 
SKK-2.3 and SKK-9.11, respond to KLH plus the transfected L  cell, although 
somewhat less well than to  KLH plus an equal number of cells of the  B  cell 
hybridoma, LK-4.5. The blocking effects of anti-L3T4  were equivalent when 
using either presenting line together with the anti-L3T4-sensitive T  cell hybrid- 
oma, SKK-2.3. A different result was observed using anti-LFA-1 as the blocking 
antibody.  The  anti-LFA-l-sensitive  hybrid  SKK-9.11  was effectively blocked GOLDE  ET  AL.  BRIEF  DEFINITIVE  REPORT  637 
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FmURE  1.  The response of a T cell hybridoma to KLH/I-A  k is unaffected by the blocking 
effects of anti-LFA-I antibody when an I-A-transfected fibroblast is used as the presenting 
cell. The T cell hybridomas SKK-2.3 and SKK-9.11 were incubated with KLH plus the B cell 
hybridoma LK-4.5 or the I-Ak-transfected fibroblast line, CA 14-11.14. Different concentra- 
tions of anti-L3T4 (e) or anti-LFA-1 (O) antibodies were added to these cultures. The effects 
of these antibodies on the responses of the T cell hybridomas were measured 24 h later by 
monitoring the concentrations of IL-2 secreted. 
when  LK-4.5  was  the presenting cell line,  but such  blocking effects were lost 
when the CA 14-11.14-transfected fibroblast was the presenting cell (Fig.  1). 
The effects of anti-L3T4 on the responses of the T  cell hybridomas, regardless 
of the presenting cell used,  is consistent with the hypothesis that  the target of 
L3T4 interaction is a nonpolymorphic determinant on the Ia molecule (I 4). The 
fact that  anti-LFA-1  had  no effect on  the response of SKK-9.11  when  L  cells 
were used as presenting  cells suggests  that  LFA-1  does not play a  role in  this 
interaction, discussed more fully below. 
A  similar result was seen when the Dd-specific T  hybridoma,  3DT-52.5,  was 
used  (Fig.  2).  This  hybridoma  responded  comparably  to  the  BALB/c  B  cell 
lymphoma A20.2J, the DBA/2 mastocytoma P815, and the Dd-transfected L cell 
line T4.8.3. KJ 12-98.5, an antibody specific for the clonotypic receptor on 3DT- 
52.5,  blocked  the  response  of the  T  cell  hybridoma  to  all  of these  cell  lines 
comparably. However, the blocking effects of anti-LFA-1  were seen only when 
the two leukocytic cell lines,  A20.2J  and  P815,  were used as targets.  No such 
blocking was observed in the response of 3DT-52.5 to T4.8.3. 
The blocking effects of anti-LFA-1  do not seem to depend on expression of 
this glycoprotein by the  APC  themselves since,  as  shown  in  Table  II,  neither 
A20-2J  nor the  L  cells and  their transfectants,  bore  LFA-I.  Thus anti-LFA-1 
antibodies  were  able  to  inhibit  Ag  presentation  by  A20-2J  to  some  T  cell 638  GOLDE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  2.  The response of a class I-specific T  cell hybridoma is insensitive to the blocking 
effects of anti-LFA-I  monoclonal  antibody  when  a  transfected  fibroblast  is  used  as  the 
stimulator. The T  cell hybridoma, 3DT-52.5, was incubated with the Dd-presenting cell lines, 
A20-2J, P815, or T4.8.3  in the presence of various concentrations of anti-3DT-52.5 receptor 
antibody (0) or anti-LFA-1  (O). The effects of these antibodies on responses were measured 
24 h  later by monitoring concentrations of IL-2 secreted. 
TABLE  II 
Expression of Cell Surface Antigens by These Cell Lines as Measured 
by ELISA 
Cell line  ELISA OD ×  l0  s* after assay with 
121/7.7 anti-LFA-1 
3DT-52.5  661  ±  88 
SKK-2.3  705 ±  45 
SKK-9.11  392 ±  37 
A20.2J  28 ±  37 
P815  287 ±  42 
LK-4.5  -3  ±  11 
T4.8.3  -68  ±  29 
L(TK-)  37 ±  67 
* OD40~ -  SE ×  10 -s. 
hybridomas, even though this cell line was LFA-1-. This result implies that LFA- 
1 inhibition acts on the LFA-l-bearing T  cell hybridomas in these cultures, and 
argues against LFA-1 functioning in a likeqike interaction. 
It is difficult to account for the variations in the effects of anti-LFA-1  that 
depend on the APC in culture, given the conclusion that the primary targets of 
these antibodies are T  cell hybridomas rather than APC. One explanation could 
be that the LFA-1  molecule is involved in the binding of some T  cells  to their 
targets, as an "accessory molecule" that interacts with an unknown ligand (not a GOLDE ET  AL.  BRIEF  DEFINITIVE REPORT  639 
TABLE III 
Anti-LFA-1 Does Not Inhibit the Response ofT Cell Hybridomas to Polyvalent Anti-receptor 
Antibodies 
T  cell hybridoma  KJ 1-26-Sepharose 
IL-2 secreted in the presence of anti-LFA-1 SN at: 
0*  2.5  5.0  I0  20  40 
U]ml 
DO-11.10  OVA/A20-2J  320  40  20  10  10  <10 
DO-I 1.10  KJ 1-26-Sepharose beads  320  320  320  320  320  160 
3DT-52.5  A20-2J  640  320  160  80  40  40 
3DT-52.5  KJ 1-26-Sepharose beads  160  160  160  160  160  160 
* Microliters ofanti-LFA-I per 250-/~1 culture of SN from 121/7.7. 
class I or class II molecule) on the target cells.  If this explanation is correct, we 
would have to propose that LFA-1 is not involved in the interaction of T  cells 
with L cells,  perhaps because L cells do not bear the ligand for LFA-1. 
If LFA-1  is simply acting as an accessory molecule in the binding of T  cells 
and their targets, then the molecule should not play a role in the interactions of 
T  cells with noncellular targets. To test this possibility, we challenged two T  cell 
hybridomas, DO-11.10  and  3DT-52.5,  either  with stimulating B  cell  targets, 
bearing OVA/I-A  d or D  °, respectively, or with stimulatory anti-receptor antibod- 
ies coupled to Sepharose beads.  As shown in  Table  III, anti-LFA-1  inhibited 
very well the responses of these T  cells to Ag/MHC presented by the  B cell 
lymphoma, A20-2J. The antibody had no effect on the responses of these T  cells 
to polyvalent anti-receptor antibody, however. 
From these experiments we concluded, as before, that LFA-1 did not play an 
essential role in T  cell activation for IL-2 production, but rather was involved in 
the interaction of T  cells with certain target cells,  which did not include L cells 
and their derivatives. 
Our future experiments will test whether LFA-1 functions when normal mouse 
fibroblasts are used as APC for T  cell hybridomas, instead of L cells. This is the 
case in man, since Collins et al. (15)  have shown that human dermal fibroblasts, 
induced to express class II molecules by gamma interferon (IFN-y), can be killed 
by class II-specific cytotoxic T  cells, and that this killing is blocked by anti-LFA- 
1 antibodies. With this in mind, we have been unable to show that Ag presentation 
by L cell lines becomes sensitive to anti-LFA-1 antibodies if the cells are prein- 
cubated with IFN-~r (data not shown); it remains to be determined if this is a 
property of L cells only or if it also extends to normal mouse fibroblasts. 
Summary 
We  show  that  the  LFA-1  molecule on  T  cells  does  not play a  role  in  the 
stimulation of T  cell hybridomas by certain targets, namely antigen presented 
by L cell derivatives or polyvalent anti-receptor antibody. These results suggest 
that LFA-1  may act by binding to ligands that are not present on all cells.  We 
hope this result will help us and others to establish the true role of LFA-1 in T 
cell responses. 
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